AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $244.9M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 16.10pm 31/07/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 45.0¢ | Day High | 47.5¢ | Day Low | 34.0¢ | |||
| Daily Volume | 9453021 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 35.5¢ | 7948 | 0 | 37.0¢ | 8712 | |
Directors & Senior Management
| Ms. Abigail Jane Mackenzie Cheadle | Independent Non-Executive Director |
| Mr. Andrew David Bennion | CEO & Executive Director |
| Mr. Andrew Mark King | CFO & Director |
| Mr. Hasaka Martin | Company Secretary |
| Mr. John Paul Drury | Chief Commercial Officer & Director |
| Mr. Julian Michael Babarczy | Independent Non-Executive Director |
| Sir Robert Ben Wallace | Independent Non-Executive Director |
| Mr. Russell Ward | Independent Chair |
| Mr. Simon Harry Shepherd | CTO & Executive Director |
Data source: ADVFN
